Carrie R Daniel, PhD, MPH
Department of Epidemiology, Division of Cancer Prevention and Population Sciences
About Dr. Carrie R Daniel-MacDougall
The primary goal of my research program is to refine and inform evidence-based dietary recommendations across the cancer continuum (i.e., from cancer prevention to improving outcomes during and after cancer treatment). As a nutritional epidemiologist, much of my work has focused on identifying diet-related risk or protective factors in large, prospective cohorts of healthy individuals followed for the development of cancer. Since joining MD Anderson in 2012, my research has been increasingly motivated by the many unanswered questions and complexities surrounding nutrition, the microbiome, obesity and inflammation in cancer patients and survivors. Together with clinical and laboratory colleagues, we continue to learn by carefully "observing" patients, collecting data and biological specimens, while also pushing forward to answer these questions more definitively in clinical trials.
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX
Regular Member, Department of Quantitative Sciences, The University of Texas Graduate School of Biological and Biomedical Sciences, Houston, TX
Resource Director, Department of Center for Energy Balance in Cancer Prevention and Survivorship, The University of Texas MD Anderson Cancer Center, Houston, TX
Director, Department of Bionutrition Research Core, The University of Texas MD Anderson Cancer Center, Houston, TX
Adjunct Faculty, Department of Epidemiology, The University of Texas - Health Houston School of Public Health, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX
Regular Member, Department of Quantitative Sciences, The University of Texas Graduate School of Biological and Biomedical Sciences, Houston, TX
Adjunct Faculty, Department of Epidemiology, Human Genetics and Environmental Sciences, The University of Texas Health Houston School of Public Health, Houston, TX
Research Interests
Building on my interests in dietary assessment methodology and biomarker-driven clinical trials, I lead MD Anderson's Bionutrition Research Core, which includes a metabolic/research kitchen and highly-trained team with culinary and dietetics expertise.
Education & Training
Degree-Granting Education
| 2008 | Emory University, Atlanta, Georgia, US, PhD in Nutrition and Health Sciences, Division of Biological and Biomedical Sciences |
| 2005 | Emory University, Atlanta, Georgia, US, MPH in Epidemiology, Rollins School of Public Health |
| 2002 | University of Arizona, Tucson, Arizona, US, BS in Molecular and Cellular Biology |
Postgraduate Training
| 2008-2012 | Cancer Research Training Award Postdoctoral Fellowship, National Cancer Institute, National Institutes of Health, Rockville, Maryland |
| 2006-2008 | Predoctoral fellow, American Cancer Society, Atlanta, GA |
Experience & Service
Faculty Academic Appointments
Assistant Professor, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2019
Administrative Appointments/Responsibilities
Resource Director, Department of Center for Energy Balance in Cancer Prevention and Survivorship, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - Present
Director, Department of Bionutrition Research Core, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2015 - Present
Other Professional Positions
Research Collaborator MD Anderson Colorectal Cancer Moon Shot, The University of Texas MD Anderson Cancer Center, 2023 - Present
Research Co-Leader, MD Anderson Patient Mosaic, The University of Texas MD Anderson Cancer Center, 2021 - Present
Nutritional and Epidemiology Lead, MD Anderson Moon Shot Platform for Innovative Microbiome and Translational Research (PRIME-TR), The University of Texas MD Anderson Cancer Center, 2020 - Present
Research Co-Leader, MD Anderson Melanoma Moon Shot, The University of Texas MD Anderson Cancer Center, 2019 - Present
Research Collaborator, MD Anderson Colorectal Cancer Bioinformatics (formerly Integromics) Working Group, The University of Texas MD Anderson Cancer Center, 2016 - Present
Research Associate, Cancer Risk Prediction and Prevention Program, Department of Epidemiology and Winship Cancer Institute, Emory University, Atlanta, GA, 2006 - 2008
Program Manager, Cancer Risk Prediction and Prevention Program, Emory University, Atlanta, GA, 2004 - 2005
Research Assistant, Severe Acute Respiratory Syndrome (SARS) Laboratory, Centers for Disease Control and Prevention, Atlanta, GA, 2003 - 2004
Research Assistant, Pediatric Nutrition Laboratory, University of Arizona Medical Center, Tucson, AZ, 2000 - 2003
Institutional Committee Activities
Member, Faculty Wellness Committee, Division of Cancer Prevention and Population Sciences, 2024 - Present
External Advisor, Expert Advisory Panel: Building a Cancer Survivor Cohort, 2023 - Present
Member, Institutional Committee, Research Enablement, Activities and Conduct Team (REACT), 2021 - Present
Member, Infectious Disease Chair Search, 2021 - 2023
Member, CCSG Microbiome Core Internal Advisory Board, 2020 - Present
Member, Psychosocial, Behavioral and Health Services Research Committee, 2019 - 2021
Member, Epidemiology Faculty Search, 2019 - Present
Member, Patient History Database/Epidemiology Data and Biorepository Resource, Data and Biospecimen Access Committee (DBAC), 2019 - Present
Member, Clinical Cancer Prevention Research Core Steering Committee, 2018 - Present
Ad Hoc Reviewer, Internal Review Study section (INTEREST), 2018 - Present
Member, CCSG Assessment, Intervention and Measurement (AIM) Core Advisory Committee, 2018 - Present
Ad Hoc Reviewer, Institutional Research Grant Peer Review Committee – Basic Science Study Section, 2017 - Present
Member, Psychosocial, Behavioral, & Health Services Research Committee, 2015 - 2016
Member, Energy Balance Faculty Search Committee, 2014 - 2020
Member, Epidemiology Faculty Mentoring Committee, 2013 - 2014
Member, DCPPS Lectureship Committee, 2013 - 2015
Member, Cancer Prevention Research Training Program (CPRTP) Advisory Committee, 2013 - Present
Member, Mexican American Cohort Internal Advisory Board, 2013 - Present
Honors & Awards
| 2021 | Regents' Outstanding Teaching Award nominee, The University of Texas MD Anderson Cancer Center |
| 2021 | President’s Recognition of Faculty Excellence Award in Education & Mentorship Advancement, The University of Texas MD Anderson Cancer Center |
| 2020 | Andrew Sabin Family Fellow |
| 2019 | Excellence in LEADership Award, The University of Texas MD Anderson Cancer Center |
| 2019 | Robert M. Chamberlain Distinguished Mentor Award Finalist, The University of Texas MD Anderson Cancer Center |
| 2018 | Early Career Women Faculty Leadership Development, Association of American Medical Colleges |
| 2018 | Leading Mentor in Cancer Prevention, The University of Texas MD Anderson Cancer Center |
| 2017 | Early Career Scholar Travel Award, Sackler Colloquium, National Academy of Sciences, John Templeton Foundation, University of Alabama at Birmingham |
| 2017 | Leading Mentor in Cancer Prevention nominee, The University of Texas MD Anderson Cancer Center |
| 2015 | USA Eisenhower Fellowship nominee (deferred) |
| 2014 | Center for Energy Balance in Cancer Prevention and Survivorship Retreat: Winner of Abstract and Presentation, The University of Texas MD Anderson Cancer Center |
| 2010 | Fellows Award for Research Excellence, National Institutes of Health |
| 2008 - 2012 | Cancer Research Training Award Fellowship, National Cancer Institute, National Institutes of Health |
| 2007 | Diet and Cancer Award Abstract and Poster Competition, American Society for Nutrition |
| 2005 - 2008 | Division Scholar Fellowship, Division of Biological and Biomedical Sciences, Graduate School of Arts of Sciences, Emory University |
| 2000 | Undergraduate Research Grant, University of Arizona Honors College and Steele Children's Research Center |
| 1999 | Pi Delta Phi, National French Honorary |
| 1998 - 2002 | John P. Shaeffer, Provost, and Spirit of Discovery Scholarships, University of Arizona |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2025. Nutrition. Invited. Young-Onset Colorectal Cancer Patient Conference. Houston, TX, US.
- 2025. Colorectal Cancer Awareness Month: MD Anderson and American Cancer Society Expert Panel and Press Conference. Invited. Houston, TX, US.
- 2024. How does diet impact cancer therapy?. Invited. MD Anderson and Kidney Cancer Association Patient and Caregiver Symposium. Houston, Texas, US.
- 2024. Monitoring and Modulating Patients’ Diets: Building the Evidence to Improve Cancer Care. Invited. Research Town Hall. Houston, Texas, US.
- 2022. Diet and the microbiome to improve outcomes for cancer patients. Invited. Cancer Prevention and Control Grand Rounds. Houston, TX, US.
- 2022. Identifying dietary components and patterns to optimize treatment response and survival in hepatocellular carcinoma (HCC) patients. Invited. Research Town Hall. Houston, Texas, US.
- 2022. Leveraging diet and the microbiome to improve outcomes for cancer patients. Invited. Department of Epidemiology Seminar Series. Houston, TX, US.
- 2021. Bionutrition Research Core. Invited. Research Town Hall. Houston, TX, US.
- 2020. Nutrition and Cancer in the Era of Obesity, the Microbiome, and Immunotherapy. Invited. UT-Health Houston Human Genetics Center. Houston, TX, US.
- 2019. Diet and the microbiome. Invited. PRIME-TR Inaugural Retreat. Houston, TX, US.
- 2018. The Importance of the Microbiome. Invited. Innovative Strategies for Improved Cancer Outcomes: Advances in Cancer Therapy. Houston, TX, US.
- 2018. Diet and the microbiome for cancer prevention, cancer patients, and cancer survivors. Invited. Gynecologic Oncology Retreat. Houston, TX, US.
- 2018. Harnessing Diet and the Microbiome for Cancer Prevention, Cancer Patients, and Cancer Survivors. Invited. Cancer Prevention and Control Grand Rounds. Houston, TX, US.
- 2017. The importance of the microbiome from cancer prevention to survival. Invited. Integrative Medicine Program Lecture Series, US.
- 2014. Energy balance and obesity: physical activity, microbiome and metabolomics. Invited. The MD Anderson Mexican American Cohort: Updates and New Directions. Houston, TX, US.
- 2014. Diet and obesity in cancer epidemiology: new insights from the microbiome and metabolome. Invited. Houston, TX, US.
- 2013. The microbiome and cancer prevention. Invited. Advances in Oncology (Session: Microbes and Cancer: The Next Questions). Houston, TX, US.
- 2013. Modifiable risk factors in cancer etiology: observational studies to evidence-based interventions. Invited. Contemporary Epidemiology: A Multilevel Approach to Personalization of Prevention and Treatment. Houston, TX, US.
- 2013. Direct and Indirect Effects of Diet in Cancer Risk. Invited. USDA ARS Children's Nutrition Research Center. Houston, TX, US.
- 2011. Meat, fish, and related mechanisms in cancer risk. Invited. Department of Epidemiology Seminar to Faculty Search Committee. Houston, TX, US.
Regional Presentations
- 2024. Gut Check: Exploring the Diet-Microbiome Axis and its Impact on Immunotherapy Outcomes. Invited. Louisiana Oncology Society 4th Annual Louisiana Cancer Congress Spring Conference (Plenary). New Orleans, LA, US.
- 2022. Navy Beans, an Accessible Prebiotic Food Source Shifts the Microbiome and Blood Metabolome of High-Risk Patients in the BE GONE Trial. Invited. Cancer and Comorbidities session, 7th Annual Cancer Health Disparities Symposium. virtual, US.
- 2020. Nutrition and Cancer in the Era of Obesity, the Microbiome, and Immunotherapy. Invited. Cancer Prevention and Control Seminar. Tucson, AZ, US.
- 2011. Diet and Renal Cancer. Invited. Lombardi Comprehensive Cancer Center. Washington, DC, US.
- 2001. Breast Milk: Effective Source of EPO growth factor for red blood cells. Conference. Undergraduate Research Program. Tucson, AZ, US.
National Presentations
- 2025. Microbiome in Food Systems. Invited. Harvard Chan Microbiome in Public Health (HCMPH) Center. Boston, MA, US.
- 2025. Diet as a precision cancer intervention. Invited. 2025 Gut Microbiota for Health World Summit. Washington, DC, US.
- 2024. Monitoring and Modulating Diet and the Gut Microbiome to Improve Outcomes for Cancer Patients. Invited. Bringing Excellence from the Laboratory to the Clinic. Aspen, CO, US.
- 2024. Monitoring and modulating diet and the gut microbiome to improve outcomes for cancer patients. Invited. Aspen, CO, US.
- 2023. Microbiome-targeted dietary interventions in melanoma: an ever-present ally to enhance immunotherapy response?. Invited. Melanoma Inter-SPORE Meeting. Pittsburgh, PA, US.
- 2022. Dietary determinants of grade progression and survival among men with prostate cancer. Invited. Prostate Cancer Foundation Population Sciences Working Group. virtual, US.
- 2022. Nutrition and the Microbiome. Invited. American Society for Therapeutic Radiation Oncology (ASTRO) Annual Meeting. San Antonio, TX, US.
- 2021. Beans to Enrich the Gut microbiome vs. Obesity’s Negative Effects: First results from the BE GONE Trial in high-risk colorectal patients. Invited. Digestive Diseases Week. Virtual, US.
- 2021. Beans to Enrich the Gut microbiome vs. Obesity’s Negative Effects: First results from the BE GONE Trial in high-risk colorectal patients. Invited. AACR Colorectal Cancer Virtual Special Conference. Virtual, US.
- 2020. Leveraging Diet and the Microbiome to Improve Cancer Outcomes. Invited. American Society for Preventive Oncology. Virtual, US.
- 2019. Lifestyle Impact on Response Immunotherapy Mediated Through the Microbiome. Invited. AICR Annual Meeting (plenary). Chapel Hill, NC, US.
- 2019. Diet, Lifestyle, and the microbiome: burgeoning targets in immunotherapy (plenary). Invited. AACR Annual Meeting (Plenary). Atlanta, GA, US.
- 2017. Microbial Allies across the Cancer Continuum: Getting to Know Our Fiber-Fermenting Friends. Invited. American College of Nutrition Annual Conference (plenary). Alexandria, VA, US.
- 2017. Microbial Allies across the Cancer Continuum: Getting to Know Our Fiber-Fermenting Friends. Invited. Discovery on Target, Microbiome in Immuno-Oncology: Influences of inflammation and nutrition. Virtual (flight canceled), US.
- 2016. Early risk signatures in the fecal microbiota of colonoscopy patients. Conference. Houston, TX, US.
- 2016. Diet quantity versus quality in relation to the fecal microbiome among colonoscopy patients. Conference. AACR Colorectal Cancer: From Initiation to Outcomes. Tampa, FL, US.
- 2015. Severe obesity and colorectal cancer patient survival. Conference. Philadelphia, PA, US.
- 2015. Gut microbiome-brain interactions in hedonic eating behaviors. Conference. Savannah, GA, US.
- 2012. Intake of fiber and fiber-rich plant foods associated with lower risk of renal cell carcinoma in a large U.S. cohort. Conference. Chicago, IL, US.
- 2011. Intake of meat mutagens and risk of non-Hodgkin lymphoma. Conference. Chemistry in Cancer Research: The Biological Chemistry of Inflammation as a Cause of Cancer. San Diego, CA, US.
- 2011. Intake of poultry and fish and risk of cancer in the NIH-AARP Diet and Health Study. Conference. Washington, DC, US.
- 2010. Meat-cooking mutagens and risk of renal cell carcinoma. Conference. AICR Food, Nutrition, Physical Activity, and Cancer Annual Meeting. Washington, DC, US.
- 2010. Anthropometric measures in South Asians. Conference. South Asian Pooling Cohort Meeting. Atlanta, GA, US.
- 2009. Dietary patterns and markers of health and nutritional status in a diverse Asian-Indian population: Preliminary results of the India Health Study. Conference. International Conference on Diet and Activity Methods (ICDAM) 7. Washington, DC, US.
- 2007. Western diet and lifestyle risk factors and expression of TGFα, TGFβ1, and TGFβRII in colon tissue. Conference. Washington, DC, US.
- 2007. TGFα and TGFβ1 levels in colon crypts, colon cancer risk factors, and incident, sporadic colorectal adenomas in the Markers of Adenomatous Polyps II (MAP II) case-control study. Conference. Anaheim, CA, US.
International Presentations
- 2025. Nutrition and Immunotherapy: Monitoring and modulating diet and the gut microbiome to improve outcomes for cancer patients. Invited. 10th Feeding Microbiota Symposium. Geneva, CH.
- 2009. Dietary patterns and scores for pooled analyses with body-size and mortality: Preliminary Analysis and Proposal. Invited. Diet Working Group of the Asia Cohort Consortium (ACC). Tokyo, JP.
Formal Peers
- 2023. Monitoring and modulating the microbiome in the setting of cancer therapy. The Bacterial-Cancer Axis: What Does it Mean?, US.
- 2022. Navy beans, an accessible prebiotic food source shifts the microbiome and blood metabolome of high-risk patients in the BE GONE Trial, US.
- 2020. Microbiome. Conference, US.
- 2019. Microbiome: Moving from Observation to Intervention and from Risk to Response to Therapy, US.
- 2018. Harnessing Diet and the Microbiome for Cancer Patient and Survivors. Conference, US.
- 2014. Diet and Cancer Prevention. Invited, US.
Grant & Contract Support
| Date: | 2026 - 2027 |
| Title: | Prebiotic diet intervention to enhance the microbiome and immunotherapy response in melanoma |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 3R01CA291965-01 |
| Date: | 2026 - 2027 |
| Title: | Prebiotic diet intervention to enhance the microbiome and immunotherapy response in melanoma |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 3R01CA291965-01 |
| Date: | 2026 - 2031 |
| Title: | Novel Cord Blood Cellular Therapies |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | P01CA148600 |
| Date: | 2025 - 2030 |
| Title: | Together stronger: A family-centered lifestyle intervention for Black prostate cancer survivors and their caregivers |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | FP00023935 |
| Date: | 2025 - 2027 |
| Title: | Circulating Microbial- and Host-Derived Metabolite Signatures for 5-year Risk Prediction of Colorectal Cancer |
| Funding Source: | NIH/NCi |
| Role: | PI |
| ID: | R21CA304519 |
| Date: | 2025 - 2030 |
| Title: | Investigating the Role of Inosinic Acid in Leaky Gut, Colon Cancer Progression, and Immune Resistance |
| Funding Source: | NCI, NIH |
| Role: | PI |
| ID: | 1R01CA303139-01 |
| Date: | 2025 - 2029 |
| Title: | IMPACT: Evaluating Feasibility and Biomarker-Related Effects of a Mediterranean Diet Intervention Among Medically Underserved Men with Prostate Cancer |
| Funding Source: | ACS |
| Role: | Co-I |
| ID: | FP00023763 |
| Date: | 2025 - 2029 |
| Title: | Bile acids as a mediator of the diet-microbiome-immune axis |
| Funding Source: | V Foundation |
| Role: | Co-I |
| ID: | FP00025623 |
| Date: | 2025 - 2030 |
| Title: | Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery |
| Funding Source: | NCI |
| Role: | Subcontract PI |
| ID: | 1R01CA293022 |
| Date: | 2025 - 2030 |
| Title: | Biobehavioral Effects of a Telehealth Comprehensive Yoga Therapy Intervention for Overweight Women with Breast Cancer |
| Funding Source: | NIH |
| Role: | Co-I |
| ID: | R01CA299968 |
| Date: | 2025 - 2029 |
| Title: | Molecular Mechanisms of Dietary Immune Modulation and Intestinal Hyperpermeability |
| Funding Source: | CPRIT |
| Role: | Co-PI |
| ID: | RP250286 |
| Date: | 2024 - 2029 |
| Title: | Dyadic-Focused Lifestyle Intervention for Black Prostate Cancer Survivors and Their Spouses: A Comparative Analysis |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Date: | 2024 - 2026 |
| Title: | Magnesium-rich dietary intervention to prevent hypomagnesemia in ovarian cancer patients undergoing platinum-based chemotherapy |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R21CA289088-01A1 |
| Date: | 2024 - 2025 |
| Title: | Priority Project 1: Microbiome and host factors across the melanoma continuum |
| Funding Source: | MD Anderson Melanoma Moonshots Program |
| Role: | PI |
| ID: | Internal |
| Date: | 2024 - 2029 |
| Title: | Mucus-degrading intestinal bacteria and toxicities of hematopoietic cell transplantation |
| Funding Source: | NIH |
| Role: | Subcontract PI |
| ID: | P01HL17004601A1 |
| Date: | 2024 - 2026 |
| Title: | High-dimensional Mediation Analysis of Cardiovascular Traits with Multi-omics Data |
| Funding Source: | NIH |
| Role: | Co-I |
| ID: | R21HL170213-01A1 |
| Date: | 2024 - 2029 |
| Title: | Prebiotic diet intervention to enhance the microbiome and immunotherapy response in melanoma |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | R01CA291965 |
| Date: | 2024 - 2028 |
| Title: | Neoadjuvant ipilimumab/nivolumab + microbiota-directed prebiotic dietary intervention to optimize immune response in melanoma |
| Funding Source: | American Cancer Society |
| Role: | Co-I |
| ID: | RSG-24-1255125-01-CPHP |
| Date: | 2024 - 2029 |
| Title: | Mucin-preserving strategies to reduce allo HCT toxicities |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01 HL174983 |
| Date: | 2024 - 2029 |
| Title: | The University of Texas MD Anderson Cancer Center SPORE in Melanoma |
| Funding Source: | NIH/NCI |
| Role: | Co-Leader (Project 1) |
| ID: | P50CA221703 |
| Date: | 2023 - 2028 |
| Title: | Prebiotic dietary intervention in melanoma patients on immunotherapy |
| Funding Source: | NIH/NCI |
| Role: | PI |
| Date: | 2023 - 2027 |
| Title: | Identification of gut microbiome signatures as biomarkers of response, recurrence, and resistance to novel chemotherapies, immunotherapies, and molecularly targeted therapies in children and adolescence |
| Funding Source: | V Foundation |
| Role: | Co-I |
| ID: | FP00017921 |
| Date: | 2023 - 2024 |
| Title: | Platform for Innovative Microbiome & Translational Research (PRIME-TR), Moon Shots™ Program, The University of Texas MD Anderson Cancer Center |
| Funding Source: | MD Anderson Cancer Center Moon Shots Program Nutrition and Epidemiology Lead |
| Role: | Nutrition and Epidemiology Lead |
| ID: | Internal |
| Date: | 2023 - 2024 |
| Title: | Elucidating the Molecular Etiology of Young-onset Colorectal Cancer: Dietary Sugar-induced Impact on Intestinal Microbiome |
| Funding Source: | MD Anderson Cancer Center Moon Shots Program |
| Role: | Co-I |
| ID: | Internal |
| Date: | 2023 - 2028 |
| Title: | Mucus-degrading intestinal bacteria and toxicities of hematopoietic cell transplantation |
| Funding Source: | NIH/NHLBI |
| Role: | Co-I |
| Date: | 2023 - 2028 |
| Title: | Prebiotic dietary intervention in melanoma patients on immunotherapy |
| Funding Source: | NIH/NCI |
| Role: | PI |
| Date: | 2022 - 2024 |
| Title: | Characterizing gut microbiome changes and elucidate the relationship between the gut microbiome and clinical outcomes in children and adolescents with central nervous system tumors |
| Funding Source: | HYUNDAI HOPE ON WHEELS |
| Role: | Co-I |
| Date: | 2022 - 2023 |
| Title: | Priority Project 1: Microbiome and host factors across the melanoma continuum |
| Funding Source: | MD Anderson Melanoma Moonshot |
| Role: | Co-PI |
| Date: | 2022 - 2027 |
| Title: | Supporting and Sustaining Behavior Change in Women at Risk for Breast Cancer Using a Comprehensive Mobile-Health Delivery Program |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01 CA272750 |
| Date: | 2022 - 2026 |
| Title: | Development and validation of a tool to assess food preparation practices related to cancer risk among Hispanics |
| Funding Source: | American Cancer Society (ACS) |
| Role: | Co-I |
| ID: | RSG0000218358 |
| Date: | 2022 - 2024 |
| Title: | Assessing food preparation behaviors related to cancer prevention among Hispanic adults |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R21 CA271124 |
| Date: | 2022 - 2027 |
| Title: | Microbiome and febrile neutropenia in patients with hematological malignancies |
| Funding Source: | NIH/NHLBI |
| Role: | Co-I |
| ID: | 1 R01 HL162781-01 |
| Date: | 2022 - 2024 |
| Title: | Dietary magnesium replacement for prevention of hypomagnesemia in ovarian cancer patients receiving platinum-based chemotherapy |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R21 CA260162 |
| Date: | 2022 - 2027 |
| Title: | Gut Microbiome and Cancer Immunotherapy Outcomes in Advanced Renal Cell Carcinoma |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1 R01 CA255322-01A1 |
| Date: | 2022 - 2025 |
| Title: | Coffee and Caffeine Metabolites and Disease Progression in Men Enrolled on Active Surveillance for Prostate Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP220425 |
| Date: | 2021 - 2023 |
| Title: | A non-invasive metabolomics-based lipid signature in localized prostate cancer patients: dietary and surgical effects |
| Funding Source: | NIH/NCI |
| Role: | Other Significant Contributor |
| ID: | 1 R03 CA255988-01A1 |
| Date: | 2021 - 2022 |
| Title: | Priority Project 1: Microbiome and host factors across the melanoma continuum |
| Funding Source: | MD Anderson Melanoma Moonshot |
| Role: | Co-PI |
| Date: | 2021 - 2026 |
| Title: | Mobile-Health Delivery of Lifestyle Interventions for Overweight Women at Risk for Breast Cancer: Mechanisms and Biobehavioral Outcomes |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1 R01 CA258419-01A1 |
| Date: | 2021 - 2026 |
| Title: | Diet and the gut microbiome in hepatocellular carcinoma patients initiating immunotherapy: new targets to improve clinical outcomes |
| Funding Source: | NIH/NCI |
| Role: | Multiple Principal Investigator |
| ID: | R01 CA266267 |
| Date: | 2021 - 2024 |
| Title: | Doris Duke-Gregg |
| Funding Source: | Doris Duke Charitable Foundation |
| Role: | Mentor |
| Date: | 2021 - 2022 |
| Title: | Noninvasive metabolomics-based prostate cancer markers: effect of dietary and surgical intervention |
| Funding Source: | Institutional Research Grant |
| Role: | Collaborator |
| ID: | RCTS#: 00059308 |
| Date: | 2020 - 2023 |
| Title: | Identifying dietary components and patterns to optimize treatment response and survival in hepatocellular carcinoma patients |
| Funding Source: | Andrew Sabin Family Foundation Fellows Award |
| Role: | PI |
| Date: | 2020 - 2025 |
| Title: | Diet and the gut microbiome in hepatocellular carcinoma prognosis and |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 1 R01 CA247919-01A1 |
| Date: | 2020 - 2025 |
| Title: | Protecting colonic mucus to mitigate acute intestinal graft-versus-host disease |
| Funding Source: | NIH/NHLBI |
| Role: | Co-I |
| ID: | R01 HL1241122 |
| Date: | 2020 - 2025 |
| Title: | Texas NORC: Linking Obesity and Nutrition Research Across Texas |
| Funding Source: | UT Health Science Center Houston |
| Role: | Core-Director |
| ID: | P30 DK128565 |
| Date: | 2020 - 2023 |
| Title: | Diet and the Gut Microbiome in Hepatocellular Carcinoma Outcomes |
| Funding Source: | Department of Defense (DOD) |
| Role: | PI |
| ID: | CA190707 |
| Date: | 2020 - 2025 |
| Title: | Diet and the gut microbiome in hepatocellular carcinoma prognosis and therapeutic response |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 1 R01 CA247919-01 |
| Date: | 2020 - 2023 |
| Title: | Diet and the microbiome in hepatocellular carcinoma outcomes |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | RP200078 |
| Date: | 2019 - 2021 |
| Title: | Controlled high-fiber dietary intervention to modulate gut microbiome in melanoma patients receiving immunotherapy |
| Funding Source: | Mark Foundation for Cancer Research |
| Role: | Co-I |
| ID: | FP00008817 |
| Date: | 2019 - 2024 |
| Title: | The University of Texas MD Anderson Cancer Center SPORE in hepatocellular carcinoma Project 3: Non-invasive assessment of liver fibrosis stage and progression in obesity and diabetes: a Hispanic population study |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | P50 CA217674 |
| Date: | 2019 - 2025 |
| Title: | Bionutrition Research Core |
| Funding Source: | SHREC Institutional Core |
| Role: | PI |
| ID: | Internal |
| Date: | 2019 - 2023 |
| Title: | High fiber diet to enhance the microbiome in immunotherapy (FP00007698) |
| Funding Source: | Rising Tide Foundation |
| Role: | Co-I |
| ID: | FP7698 |
| Date: | 2019 - 2022 |
| Title: | Lipidomics-based Biomarkers and Therapy for Early Prostate Cancer in African Americans |
| Funding Source: | Department of Defense (DOD) |
| Role: | Co-I |
| ID: | PC180198 |
| Date: | 2019 - 2024 |
| Title: | Delineating the influence of diet-microbiome interactions on response to immune checkpoint blockade |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | 1 R01 CA241996-01 |
| Date: | 2019 - 2024 |
| Title: | (PQ11) Appraising the role of patients' diet quality in hepatocellular carcinoma prognosis and therapeutic response |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | R01 CA238836 |
| Date: | 2019 - 2022 |
| Title: | Molecular Epidemiology of Cholangiocarcinoma |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP190232 |
| Date: | 2019 - 2021 |
| Title: | Diet-microbiome interactions in hepatocellular carcinoma (HCC) etiology and outcomes |
| Funding Source: | CCSG Prevention and Population Science Research Programs Seed Funding Initiative |
| Role: | PI |
| Date: | 2019 - 2023 |
| Title: | Weight Control Intervention in Obese and/or Diabetic Adults with Liver Fibrosis |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01 CA235728 |
| Date: | 2019 - 2023 |
| Title: | Project 2: Weight control intervention in obese and/or diabetic hispanics with liver fibrosis |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP180688 |
| Date: | 2018 - 2023 |
| Title: | Diet, mental health, and the microbiome in response to immunotherapy |
| Funding Source: | Melanoma Research Alliance |
| Role: | Co-I |
| ID: | MRA#564449 |
| Date: | 2018 - 2023 |
| Title: | (PQ 11) Dietary sugar and breast cancer response to chemotherapy |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | R01 CA227390 |
| Date: | 2018 - Present |
| Title: | Beans against bacteria: a crossover trial in obese colorectal adenoma patients |
| Funding Source: | Dry Bean Health Research Program |
| Role: | PI |
| Date: | 2017 - 2020 |
| Title: | Molecular, Immune and Clinical Significance of Obesity in Advanced Melanoma |
| Funding Source: | Conquer Cancer Foundation |
| Role: | Co-I |
| ID: | FP00000184 |
| Date: | 2017 - 2023 |
| Title: | BE GONE Trial: Beans to Enrich the Gut of Obese Colorectal Cancer Survivors |
| Funding Source: | American Cancer Society (ACS) |
| Role: | PI |
| ID: | RSG-17-049-01-NEC |
| Date: | 2017 - 2022 |
| Title: | Effects of a dry bean intervention on host-gut microbiota interactions in obese colorectal adenoma patients |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | R01 CA221622 |
| Date: | 2016 - 2022 |
| Title: | Physical Activity Among Racial/Ethnic and Age-Diverse Individuals: Mapping Molecular Transducers |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | U01 AR071122 |
| Date: | 2016 - 2017 |
| Title: | The Beans to Enrich the Gut microbiome vs. Obesity's Negative Effects (BE GONE) Pilot Trial |
| Funding Source: | Institutional Research Grant |
| Role: | PI |
| Date: | 2016 - 2018 |
| Title: | Beans against bacteria: a crossover trial in obese colorectal adenoma patients |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 1R21CA195171-01A1 |
| Date: | 2016 - 2018 |
| Title: | Urological Concerns Associated with Testosterone Deficiency or Therapy in A Representative Sample of the U.S. Population |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R21DK109469 |
| Date: | 2016 - 2019 |
| Title: | BE GONE trial: beans to enrich the gut of obese colorectal cancer survivors |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | RP160228 |
| Date: | 2015 - 2016 |
| Title: | A systemic study of microRNAs in the susceptibility and outcome of esophageal adenocarcinoma |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1R01 CA203225-01 |
| Date: | 2015 - 2017 |
| Title: | Beans against bacteria: a crossover trial in obese colorectal adenoma patients |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | R21 CA195171-01 |
| Date: | 2015 - 2020 |
| Title: | Gut-Microbiome-Brain Interactions in Hedonic Eating Behaviors |
| Funding Source: | NIH |
| Role: | Co-PI |
| ID: | R01 OD020588 |
| Date: | 2015 - 2020 |
| Title: | Bionutrition Research Core |
| Funding Source: | Duncan Family Institute Strategic Initiative |
| Role: | PI |
| Date: | 2015 - 2019 |
| Title: | Pathways Linking Acculturation and Obesity Risk in Mexican Americans |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1-R01-MD009716-01 |
| Date: | 2015 - 2020 |
| Title: | Multi-ethnic Cancer Survivorship Cohort |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | U01 CA195566A |
| Date: | 2015 - 2020 |
| Title: | Examining the Effects of Sugar in Promoting the Development of Breast Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | R01 CA194735 |
| Date: | 2015 - 2018 |
| Title: | An Integrative Approach to Identifying Novel Predictors of Smoking and BMI Trajectories in a Prospective Cohort of Mexican American Adolescents |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP150022 |
| Date: | 2014 - 2016 |
| Title: | (PQA1)Gut-Microbiome-Brain Interactions In Hedonic Eating Behaviors |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | R21 CA190037 |
| Date: | 2014 - 2017 |
| Title: | Identifying novel predictors of weight gain in a prospective cohort of Mexican American adults: a multilevel approach |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | RP14025 |
| Date: | 2014 - 2020 |
| Title: | Discovery of Risk Loci and Genomics of Pancreatic Cancer through Exome Sequencing |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01 CA181244 |
| Date: | 2014 - 2019 |
| Title: | Dopamine genes predict health-related behaviors in Mexican American young adults |
| Funding Source: | NIH/NCI |
| Role: | Multiple Principal Investigator |
| ID: | R01 CA188115 |
| Date: | 2014 - 2019 |
| Title: | Pathways linking acculturation and obesity risk in Mexican Americans |
| Funding Source: | NIH/NIMH |
| Role: | Co-I |
| ID: | R01 |
| Date: | 2014 - 2019 |
| Title: | Epigenetics: linking early life events to smoking uptake in Mexican origin youth |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Date: | 2014 - 2019 |
| Title: | Next generation sequencing to identify novel colorectal cancer genes |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01CA177935 |
| Date: | 2014 - 2016 |
| Title: | Biobehavioral Predictors of Weight Gain in a Young Mexican-American Cohort |
| Funding Source: | NIH/NIDDK |
| Role: | PI |
| ID: | R21 DK102098 |
| Date: | 2014 - 2016 |
| Title: | Gut Microbiome: integrating risk pathways in obesity and colorectal neoplasia |
| Funding Source: | Duncan Family Institute |
| Role: | PI |
| Date: | 2014 - 2019 |
| Title: | Acculturation trajectory in Mexican immigrants: health behaviors and biology |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | PAR-10-136 |
| Date: | 2014 - 2019 |
| Title: | Stress, Socioeconomic Status, Obesity, and Fatigue in Breast Cancer Survivors |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01 |
| Date: | 2013 - 2017 |
| Title: | Mexican American Nutrition Cohort Initiative |
| Funding Source: | Duncan Family Institute New Strategic Research Initiative |
| Role: | PI |
| Date: | 2013 - 2017 |
| Title: | Metabolic syndrome components in Hispanic young adults: a biobehavioral approach |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Date: | 2012 - 2016 |
| Title: | Molecular Pathways Linking Obesity and RCC Tumorigeneis (PQ1) |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01CA170298 |
| Date: | 2007 |
| Title: | Effects of Supplemental Antioxidants on Biomarkers of Oxidative Stress and Inflammation in the Normal Colon Epithelium and Blood of Persons at Increased Risk for Colorectal Cancer |
| Funding Source: | Emory Center for Clinical and Molecular Nutrition Feasibility Award |
| Role: | Co-I |
Selected Publications
Peer-Reviewed Articles
- Farias RM, Jiang Y, Levy EJ, Hwang C, Wang J, Burton EM, Cohen L, Ajami N, Wargo JA, Daniel CR, McQuade JL. Diet and Immune Effects Trial (DIET)- a randomized, double-blinded dietary intervention study in patients with melanoma receiving immunotherapy. BMC Cancer 24(1):1493, 2024. e-Pub 2024. PMID: 39633321.
- Gregg JR, Newcomb L, Wu R, Dennison J, Davis JW, Pettaway C, Pisters L, Ward JF, Chapin BF, Chery L, Urkmez A, Fang AM, Higgason N, Troncoso P, Daniel CR, Logothetis C, Thompson TC, Hahn AW, Liu M, Zheng Y, Lin DW, Hanash S, Irajizad E, Fahrmann J. Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance. Biomark Res 12(1):134, 2024. e-Pub 2024. PMID: 39522029.
- Li F, Yano Y, Etievant L, Daniel CR, Sharma SV, Brown EL, Li R, Loftfield E, Lan Q, Sinha R, Moshiree B, Inoue-Choi M, Vogtmann E. The Time-Dependent Association Between Irritable Bowel Syndrome and All-Cause and Cause-Specific Mortality: A Prospective Cohort Study Within the UK Biobank. Am J Gastroenterol 119(7):1373-1382, 2024. e-Pub 2024. PMID: 38275237.
- Gregg JR, Magill RG, Fang AM, Chapin BF, Davis JW, Adibi M, Chery LJ, Papadopoulos JN, Pettaway CA, Pisters LL, Ward J, Hahn AW, Daniel-MacDougall CR, Bhaskaran J, Zhu K, Guerrero M, Zhang M, Troncoso P. The association of body mass index with tumor aggression among men undergoing radical prostatectomy. Urologic Oncology: Seminars and Original Investigations 42(4):116.e1-116.e7, 2024. e-Pub 2024. PMID: 38262868.
- Zhang X, Daniel CR, Soltero V, Vargas X, Jain S, Kanwal F, Thrift AP, Balakrishnan M. A Study of Dietary Patterns Derived by Cluster Analysis and Their Association With Metabolic Dysfunction-Associated Steatotic Liver Disease Severity Among Hispanic Patients. Am J Gastroenterol 119(3):505-511, 2024. e-Pub 2024. PMID: 37737674.
- Sheshadri A, Rajaram R, Baugh A, Castro M, Correa A, Soto F, Daniel-MacDougall CR, Li L, Evans SE, Dickey BF, Vaporciyan AA, Ost DE. Association of Pre-operative Lung Function with Complications after Lobectomy Using Race-Neutral and Race-Specific Normative Equations. Ann Am Thorac Soc 21(1):38-46, 2024. e-Pub 2023. PMID: 37796618.
- Zhang X, Irajizad E, Hoffman KL, Fahrmann JF, Li F, Seo YD, Browman G, Dennison JB, Vykoukal JV, Luna PN, Siu W, Wu R, Murage EN, Ajami NJ, McQuade JL, Wargo J, Long JP, Do K, Lampe JW, Basen-Engquist KM, Okhuysen PC, Kopetz S, Hanash S, Petrosino JF, Scheet PA, Daniel CR. Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites. EBioMedicine 98, 2023. e-Pub 2023. PMID: 38040541.
- Li F, Ramirez Y, Yano Y, Daniel-MacDougall CR, Sharma SV, Brown EL, Li R, Moshiree B, Loftfield E, Lan Q, Sinha R, Inoue-Choi M, Vogtmann E. The association between inflammatory bowel disease and all-cause and cause-specific mortality in the UK Biobank. Annals of epidemiology 88:15-22, 2023. e-Pub 2023. PMID: 38013230.
- Altan M, Soto F, Zhong LL, Akhmedzhanov FO, Wilson NR, Zarifa A, Albittar AA, Yang V, Lewis J, Rinsurongkawong W, Jack Lee J, Rinsurongkawong V, Zhang J, Gibbons DL, Vaporciyan AA, Jennings K, Khawaja F, Faiz SA, Shannon VR, Shroff G, Godoy MCB, Daver NG, Gandhi S, Mendoza TR, Naing A, Daniel-MacDougall C, Heymach JV, Sheshadri A. Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience. Oncologist 28(11):E1065-E1074, 2023. e-Pub 2023. PMID: 37156009.
- Altan M, Soto F, Xu T, Wilson N, Franco-Vega MC, Simbaqueba Clavijo CA, Shannon VR, Faiz SA, Gandhi S, Lin SH, Lopez P, Zhong L, Akhmedzhanov F, Godoy MCB, Shroff GS, Wu J, Khawaja F, Kim ST, Naing A, Heymach JV, Daniel-Macdougall C, Liao Z, Sheshadri A. Pneumonitis After Concurrent Chemoradiation and Immune Checkpoint Inhibition in Patients with Locally Advanced Non-small Cell Lung Cancer. Clin Oncol (R Coll Radiol) 35(10):630-639, 2023. e-Pub 2023. PMID: 37507279.
- Witt RG, Cass SH, Tran T, Damania A, Nelson EE, Sirmans E, Burton EM, Chelvanambi M, Johnson S, Tawbi HA, Gershenwald JE, Davies MA, Spencer C, Mishra A, Wong MC, Ajami NJ, Peterson CB, Daniel CR, Wargo JA, McQuade JL, Nelson KC. Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma. JAMA Dermatol 159(10):1076-1084, 2023. e-Pub 2023. PMID: 37647056.
- Gregg JR, Kim J, Logothetis C, Hanash S, Zhang X, Manyam G, Muir K, Group UC, Giles GG, Stanford JL, Berndt SI, Kogevinas M, Brenner H, Eeles RA, Consortium P, Wei P, Daniel CR. Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate Cancer. Eur Urol Oncol 6(3):282-288, 2023. e-Pub 2023. PMID: 35995710.
- Hahn AW, Menk AV, Rivadeneira DB, Augustin RC, Xu M, Li J, Wu X, Mishra AK, Gide TN, Quek C, Zang Y, Spencer CN, Menzies AM, Daniel CR, Hudgens CW, Nowicki T, Haydu LE, Khan MAW, Gopalakrishnan V, Burton EM, Malke J, Simon JM, Bernatchez C, Putluri N, Woodman SE, Vashisht Gopal YN, Guerrieri R, Fischer GM, Wang J, Wani KM, Thompson JF, Lee JE, Hwu P, Ajami N, Gershenwald JE, Long GV, Scolyer RA, Tetzlaff MT, Lazar AJ, Schadendorf D, Wargo JA, Kirkwood JM, DeBerardinis RJ, Liang H, Futreal A, Zhang J, Wilmott JS, Peng W, Davies MA, Delgoffe GM, Najjar YG, McQuade JL. Obesity is associated with altered tumor metabolism in metastatic melanoma. Clin Cancer Res 29(1):154-164, 2023. e-Pub 2023. PMID: 36166093.
- Schwabkey ZI, Wiesnoski DH, Chang CC, Tsai WB, Pham D, Ahmed SS, Hayase T, Ortega Turrubiates MR, El-Himri RK, Sanchez CA, Hayase E, Frenk Oquendo AC, Miyama T, Halsey TM, Heckel BE, Brown AN, Jin Y, Raybaud M, Prasad R, Flores I, McDaniel L, Chapa V, Lorenzi PL, Warmoes MO, Tan L, Swennes AG, Fowler S, Conner M, McHugh K, Graf T, Jensen VB, Peterson CB, Do KA, Zhang L, Shi Y, Wang Y, Galloway-Pena JR, Okhuysen PC, Daniel-MacDougall CR, Shono Y, Burgos da Silva M, Peled JU, van den Brink MRM, Ajami N, Wargo JA, Reddy P, Valdivia RH, Davey L, Rondon G, Srour SA, Mehta RS, Alousi AM, Shpall EJ, Champlin RE, Shelburne SA, Molldrem JJ, Jamal MA, Karmouch JL, Jenq RR. Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment. Sci Transl Med 14(671):eabo3445, 2022. e-Pub 2022. PMID: 36383683.
- Kwan SY, Jiao J, Joon A, Wei P, Petty LE, Below JE, Daniel CR, Wu X, Zhang J, Jenq RR, Futreal PA, Hawk ET, McCormick JB, Fisher-Hoch SP, Beretta L. Gut Microbiome Features Associated with Liver Fibrosis in Hispanics, a Population at High Risk for Fatty Liver Disease. Hepatology 75(4):955-967, 2022. e-Pub 2022. PMID: 34633706.
- Lopez DS, Liu L, Smith-Warner SA, Tsilidis KK, Daniel C, Baillargeon J, Rohrmann S, Platz EA, Giovannucci E. Association of Prudent, Western, and Alternate Healthy Eating Index (AHEI-2010) dietary patterns with serum testosterone and sex hormone binding globulin levels in men. Hormones (Athens) 21(1):113-125, 2022. e-Pub 2022. PMID: 35015287.
- Li D, Zheng J, Hatia R, Hassan M, Daniel CR. Dietary Intake of Fatty Acids and Risk of Pancreatic Cancer: A Case-control Study. J Nutr 152(2):439-447, 2022. e-Pub 2022. PMID: 34665254.
- Heredia NI, Zhang X, Balakrishnan M, Daniel CR, Hwang JP, McNeill LH, Thrift AP. Physical activity and diet quality in relation to non-alcoholic fatty liver disease: A cross-sectional study in a representative sample of U.S. adults using NHANES 2017-2018. Prev Med 154:106903, 2022. e-Pub 2022. PMID: 34861339.
- Spencer CN, McQuade JL, Gopalakrishnan V, McCulloch JA, Vetizou M, Cogdill AP, Khan MAW, Zhang X, White MG, Peterson CB, Wong MC, Morad G, Rodgers T, Badger JH, Helmink BA, Andrews MC, Rodrigues RR, Morgun A, Kim YS, Roszik J, Hoffman KL, Zheng J, Zhou Y, Medik YB, Kahn LM, Johnson S, Hudgens CW, Wani K, Gaudreau PO, Harris AL, Jamal MA, Baruch EN, Perez-Guijarro E, Day CP, Merlino G, Pazdrak B, Lochmann BS, Szczepaniak-Sloane RA, Arora R, Anderson J, Zobniw CM, Posada E, Sirmans E, Simon J, Haydu LE, Burton EM, Wang L, Dang M, Clise-Dwyer K, Schneider S, Chapman T, Anang NAS, Duncan S, Toker J, Malke JC, Glitza IC, Amaria RN, Tawbi HA, Diab A, Wong MK, Patel SP, Woodman SE, Davies MA, Ross MI, Gershenwald JE, Lee JE, Hwu P, Jensen V, Samuels Y, Straussman R, Ajami NJ, Nelson KC, Nezi L, Petrosino JF, Futreal PA, Lazar AJ, Hu J, Jenq RR, Tetzlaff MT, Yan Y, Garrett WS, Huttenhower C, Sharma P, Watowich SS, Allison JP, Cohen L, Trinchieri G, Daniel CR, Wargo JA. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science 374(6575):1632-1640, 2021. e-Pub 2021. PMID: 34941392.
- Zheng J, Daniel CR, Hatia RI, Stuff J, Abdelhakeem AA, Rashid A, Chun YS, Jalal PK, Kaseb AO, Li D, Hassan MM. Dietary N-Nitroso Compounds and Risk of Hepatocellular Carcinoma: A US-Based Study. Hepatology 74(6):3161-3173, 2021. e-Pub 2021. PMID: 34233041.
- John JC, Wang J, McNeill LHM, Basen-Engquist K, Hoover DS, Daniel CR, Strong LL. A Mixed Methods Study on Engagement and Satisfaction with a Digitally-Enhanced Pilot Intervention Among African American and Hispanic Women. J Immigr Minor Health 23(5):1011-1020, 2021. e-Pub 2021. PMID: 33043411.
- Moussa I, Day RS, Li R, Kaseb A, Jalal PK, Daniel-MacDougall C, Hatia RI, Abdelhakeem A, Rashid A, Chun YS, Li D, Hassan MM. Association of dietary fat intake and hepatocellular carcinoma among US adults. Cancer Med 10(20):7308-7319, 2021. e-Pub 2021. PMID: 34535983.
- Deweese MM, Versace F, Kypriotakis G, Dirba D, Daniel CR, Schembre SM. Satiety does not affect neuroaffective electrophysiological responses to food-related or emotional visual cues. Behav Neurosci 135(4):571-580, 2021. e-Pub 2021. PMID: 33844564.
- Moussa I, Day RS, Li R, Du XL, Kaseb AO, Jalal PK, Daniel-MacDougall C, Hatia RI, Abdelhakeem A, Rashid A, Chun YS, Li D, Hassan MM. Dietary Patterns and Hepatocellular Carcinoma Risk among US Adults. Nutrients 13(6), 2021. e-Pub 2021. PMID: 34208122.
- Advani SM, Swartz MD, Loree J, Davis JS, Sarsashek AM, Lam M, Lee MS, Bressler J, Lopez DS, Daniel CR, Morris V, Shureqi I, Kee B, Dasari A, Vilar E, Overman M, Hamilton S, Maru D, Braithwaite D, Kopetz S. Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer. Clin Colorectal Cancer 20(2):137-147.e1, 2021. e-Pub 2021. PMID: 33229221.
- Gregg JR, Zhang X, Chapin BF, Ward JF, Kim J, Davis JW, Daniel CR. Adherence to the Mediterranean diet and grade group progression in localized prostate cancer: An active surveillance cohort. Cancer 127(5):720-728, 2021. e-Pub 2021. PMID: 33411364.
- Zhang X, Hoffman KL, Wei P, Elhor Gbito KY, Joseph R, Li F, Scheet P, Chang S, Petrosino JF, Daniel CR. Baseline oral microbiome and all-cancer incidence in a cohort of non-smoking Mexican American women. Cancer Prev Res (Phila) 14(3):383-392, 2021. e-Pub 2021. PMID: 33277317.
- Gregg JR, Surasi DS, Childs A, Moll N, Ward JF, Kim J, Daniel CR, Logothetis C, Bathala T, Davis JW. The Association of Periprostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active Surveillance. J Urol 205(1):101097JU0000000000001321, 2021. e-Pub 2021. PMID: 32718204.
- Zheng J, Hoffman KL, Chen JS, Shivappa N, Sood A, Browman GJ, Dirba DD, Hanash S, Wei P, Hebert JR, Petrosino JF, Schembre SM, Daniel CR. Dietary inflammatory potential in relation to the gut microbiome: results from a cross-sectional study. Br J Nutr 124(9):1-12, 2020. e-Pub 2020. PMID: 32475373.
- Bigman G, Wilkinson AV, Vandewater EA, Daniel CR, Koehly LM, Spitz MR, Sargent JD. Viewing images of alcohol use in PG-13-rated movies and alcohol initiation in Mexican-heritage youth. J Ethn Subst Abuse 19(4):1-16, 2020. e-Pub 2020. PMID: 30652524.
- Koslovsky MD, Hoffman, KL, Daniel, CR, Vannucci M. A Bayesian model of microbiome data for simultaneous identification of covariate associations and prediction of phenotypic outcomes. The Annals of Applied Statistics 14(3):1471-1492, 2020. e-Pub 2020.
- Holly AE, Lee KA, Daniel CR, Spector TD, McQuade JL. Patient Nutrition: An Overlooked Yet Emerging Variable in the Precision Oncology Equation. J Immunother Precis Oncol 3(3):108-112, 2020. e-Pub 2020. PMID: 35663260.
- Zhang X, Browman G, Siu W, Basen-Engquist KM, Hanash SM, Hoffman KL, Okhuysen PC, Scheet P, Petrosino JF, Kopetz S, Daniel CR. The BE GONE trial study protocol: a randomized crossover dietary intervention of dry beans targeting the gut microbiome of overweight and obese patients with a history of colorectal polyps or cancer. BMC Cancer 19(1):1233, 2019. e-Pub 2019. PMID: 31852462.
- Sims TT, Colbert LE, Zheng J, Delgado Medrano AY, Hoffman KL, Ramondetta L, Jazaeri A, Jhingran A, Schmeler KM, Daniel CR, Klopp A. Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls. Gynecol Oncol 155(2):237-244, 2019. e-Pub 2019. PMID: 31500892.
- Advani SM, Advani PS, Brown DW, DeSantis SM, Korphaisarn K, VonVille HM, Bressler J, Lopez DS, Davis JS, Daniel CR, Sarshekeh AM, Braithwaite D, Swartz MD, Kopetz S. Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer. BMC Cancer 19(1):964, 2019. e-Pub 2019. PMID: 31623592.
- Li D, Tang H, Wei P, Zheng J, Daniel CR, Hassan MM. Vitamin C and Vitamin E Mitigate the Risk of Pancreatic Ductal Adenocarcinoma from Meat-Derived Mutagen Exposure in Adults in a Case-Control Study. J Nutr 149(8):1443-1450, 2019. e-Pub 2019. PMID: 31100111.
- Zheng J, Stuff J, Tang H, Hassan MM, CR D, Li D. Dietary N-nitroso compounds and risk of pancreatic cancer: results from a large case-control study. Carcinogenesis 40(2):254-262, 2019. e-Pub 2019. PMID: 30475991.
- Gregg JR, Zheng J, Lopez DS, Reichard C, Browman G, Chapin B, Kim J, Davis J, Daniel CR. Diet quality and Gleason grade progression among localised prostate cancer patients on active surveillance. Br J Cancer 120(4):466-471, 2019. e-Pub 2019. PMID: 30679782.
- Gregg JR, Lopez DS, Reichard C, Zheng J, Wu W, Ye Y, Chapin B, Kim J, Daniel CR, Davis J. Coffee, Caffeine Metabolism Genotype, and Disease Progression in Localized Prostate Cancer Patients Managed with Active Surveillance. J Urol 201(2):308-314, 2019. e-Pub 2019. PMID: 30179617.
- Heredia NI, Wilkinson AV, Forman MR, Christie IC, Wang J, Daniel CR, Zhao H, Bondy ML, Strong LL. Longitudinal associations of family functioning with body mass index in Mexican-origin adolescents living in the U.S. Prev Med 118:309-316, 2019. e-Pub 2019. PMID: 30419254.
- Advani SM, Advani P, DeSantis SM, Brown D, VonVille HM, Lam M, Loree JM, Mehrvarz Sarshekeh A, Bressler J, Lopez DS, Daniel CR, Swartz MD, Kopetz S. Clinical, Pathological, and Molecular Characteristics of CpG Island Methylator Phenotype in Colorectal Cancer: A Systematic Review and Meta-analysis. Transl Oncol 11(5):1188-1201, 2018. e-Pub 2018. PMID: 30071442.
- McQuade JL, Daniel CR, Hess KR, Mak C, Wang DY, Rai RR, Park JJ, Haydu LE, Spencer C, Wongchenko M, Lane S, Lee DY, Kaper M, McKean M, Beckermann KE, Rubinstein SM, Rooney I, Musib L, Budha N, Hsu J, Nowicki TS, Avila A, Haas T, Puligandla M, Lee S, Fang S, Wargo JA, Gershenwald JE, Lee JE, Hwu P, Chapman PB, Sosman JA, Schadendorf D, Grob JJ, Flaherty KT, Walker D, Yan Y, McKenna E, Legos JJ, Carlino MS, Ribas A, Kirkwood JM, Long GV, Johnson DB, Menzies AM, Davies MA. Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. Lancet Oncol 19(3):310-322, 2018. e-Pub 2018. PMID: 29449192.
- Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, Petaccia de Macedo M, Cotechini T, Kumar T, Chen WS, Reddy SM, Szczepaniak Sloane R, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LM, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Marcelo Riquelme Sanchez E, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359(6371):97-103, 2018. e-Pub 2018. PMID: 29097493.
- Hoffman KL, Hutchinson DS, Fowler J, Smith DP, Ajami NJ, Zhao H, Scheet P, Chow WH, Petrosino JF, Daniel CR. Oral microbiota reveals signs of acculturation in Mexican American women. PLoS One 13(4):e0194100, 2018. e-Pub 2018. PMID: 29694348.
- Zhao H, Han L, Chang D, Ye Y, Shen J, Daniel CR, Gu J, Chow WH, Wu X. Social-demographics, health behaviors, and telomere length in the Mexican American Mano a Mano Cohort. Oncotarget 8(57):96553-96567, 2017. e-Pub 2017. PMID: 29228552.
- Zhao H, Shen J, Daniel-MacDougall C, Wu X, Chow WH. Plasma MicroRNA signature predicting weight gain among Mexican-American women. Obesity (Silver Spring) 25(5):958-964, 2017. e-Pub 2017. PMID: 28342299.
- Chrisman M, Chow WH, Daniel CR, Wu X, Zhao H. Associations between language acculturation, age of immigration, and obesity in the Mexican American Mano A Mano cohort. Obes Res Clin Pract. e-Pub 2017. PMID: 28420589.
- Wilkinson AV, Miller EE, Koehly LM, Daniel CR, Forman MR. Correlates of Physical Activity Differ by Sex and Country of Birth Among Mexican-Heritage Youth. J Immigr Minor Health 19(2):246-253, 2017. e-Pub 2017. PMID: 27341817.
- Chow WH, Chrisman M, Daniel CR, Ye Y, Gomez H, Dong Q, Anderson CE, Chang S, Strom S, Zhao H, Wu X. Cohort Profile: The Mexican American Mano a Mano Cohort. Int J Epidemiol 46(2):e3, 2017. e-Pub 2017. PMID: 25747868.
- Zhao H, Shen J, Djukovic D, Daniel-MacDougall C, Gu H, Wu X, Chow WH. Metabolomics-identified metabolites associated with body mass index and prospective weight gain among Mexican American women. Obes Sci Pract 2(3):309-317, 2016. e-Pub 2016. PMID: 27708848.
- Chrisman M, Chow WH, Daniel CR, Wu X, Zhao H. Mobile Phone Use and its Association With Sitting Time and Meeting Physical Activity Recommendations in a Mexican American Cohort. JMIR Mhealth Uhealth 4(2):e54, 2016. e-Pub 2016. PMID: 27311831.
- Melkonian SC, Daniel CR, Ye Y, Pierzynski JA, Roth JA, Wu X. Glycemic Index, Glycemic Load, and Lung Cancer Risk in Non-Hispanic Whites. Cancer Epidemiol Biomarkers Prev 25(3):532-9, 2016. e-Pub 2016. PMID: 26944871.
- Palacios C, Daniel CR, Tirado-Gómez M, Gonzalez-Mercado V, Vallejo L, Lozada J, Ortiz A, Hughes DC, Basen-Engquist K. Dietary Patterns in Puerto Rican and Mexican-American Breast Cancer Survivors: A Pilot Study. J Immigr Minor Health. e-Pub 2016. PMID: 26984227.
- Anderson C, Zhao H, Daniel CR, Hromi-Fiedler A, Dong Q, Elhor Gbito KY, Wu X, Chow WH. Acculturation and Diabetes Risk in the Mexican American Mano a Mano Cohort. Am J Public Health 106(3):547-9, 2016. e-Pub 2016. PMID: 26794174.
- Daniel CR, Shu X, Ye Y, Gu J, Raju GS, Kopetz S, Wu X. Severe obesity prior to diagnosis limits survival in colorectal cancer patients evaluated at a large cancer centre. Br J Cancer 114(1):103-9, 2016. e-Pub 2016. PMID: 26679375.
- Melkonian SC, Daniel CR, Ye Y, Tannir NM, Karam JA, Matin SF, Wood CG, Wu X. Gene-environment interaction of genome-wide association study-identified susceptibility loci and meat-cooking mutagens in the etiology of renal cell carcinoma. Cancer 122(1):108-15, 2016. e-Pub 2016. PMID: 26551148.
- Chrisman M, Daniel CR, Chow WH, Wu X, Zhao H. Acculturation, sociodemographic and lifestyle factors associated with compliance with physical activity recommendations in the Mexican-American Mano A Mano cohort. BMJ Open 5(11):e008302, 2015. e-Pub 2015. PMID: 26608633.
- Shah MS, Fogelman DR, Raghav KP, Heymach JV, Tran HT, Jiang ZQ, Kopetz S, Daniel CR. Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancer. Cancer 121(17):2968-75, 2015. e-Pub 2015. PMID: 25975416.
- Tu H, Ahearn TU, Daniel CR, Gonzalez-Feliciano AG, Seabrook ME, Bostick RM. Transforming growth factors and receptor as potential modifiable pre-neoplastic biomarkers of risk for colorectal neoplasms. Mol Carcinog 54(9):821-30, 2015. e-Pub 2015. PMID: 24719252.
- Tu H, Flanders WD, Ahearn TU, Daniel CR, Gonzalez-Feliciano AG, Long Q, Rutherford RE, Bostick RM. Effects of Calcium and Vitamin D3 on TGFα and. Mol Carcinog 54(4):270-80, 2015. e-Pub 2015. PMID: 24166893.
- Melkonian SC, Daniel CR, Hildebrandt MA, Tannir NM, Ye Y, Chow WH, Wood CG, Wu X. Joint association of genome-wide association study-identified susceptibility Loci and dietary patterns in risk of renal cell carcinoma among non-Hispanic whites. Am J Epidemiol 180(5):499-507, 2014. e-Pub 2014. PMID: 25053674.
- Daniel CR, Kapur K, McAdams MJ, Dixit-Joshi S, Devasenapathy N, Shetty H, Hariharan S, George PS, Mathew A, Sinha R. Development of a field-friendly automated dietary assessment tool and nutrient database for India. Br J Nutr 111(1):1-12, 2014. e-Pub 2014. PMID: 23796477.
- Lopez DS, Wang R, Tsilidis KK, Zhu H, Daniel CR, Sinha A, Canfield S. Role of Caffeine Intake on Erectile Dysfunction in US Men: Results from NHANES 2001-2004. PLoS One 10(4):e0123547, 2014. e-Pub 2014. PMID: 25919661.
- Daniel CR, Park Y, Chow WH, Graubard BI, Hollenbeck AR, Sinha R. Intake of fiber and fiber-rich plant foods is associated with a lower risk of renal cell carcinoma in a large US cohort. Am J Clin Nutr 97(5):1036-43, 2013. e-Pub 2013. PMID: 23515007.
- Dellavalle CT, Daniel CR, Aschebrook-Kilfoy B, Hollenbeck AR, Cross AJ, Sinha R, Ward MH. Dietary intake of nitrate and nitrite and risk of renal cell carcinoma in the NIH-AARP Diet and Health Study. Br J Cancer 108(1):205-12, 2013. e-Pub 2013. PMID: 23169285.
- Moore SC, Gunter MJ, Daniel CR, Reddy KS, George PS, Yurgalevitch S, Devasenapathy N, Ramakrishnan L, Chatterjee N, Chanock SJ, Berndt SI, Mathew A, Prabhakaran D, Sinha R. Common Genetic Variants and Central Adiposity Among Asian-Indians. Obesity (Silver Spring) 20(9):1902-8, 2012. e-Pub 2012. PMID: 21799482.
- Sinha R, Cross AJ, Daniel CR, Graubard BI, Wu JW, Hollenbeck AR, Gunter MJ, Park Y, Freedman ND. Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study. Am J Clin Nutr 96(2):374-81, 2012. e-Pub 2012. PMID: 22695871.
- Daniel CR, Sinha R, Park Y, Graubard BI, Hollenbeck AR, Morton LM, Cross AJ. Meat intake is not associated with risk of non-hodgkin lymphoma in a large prospective cohort of U.S. men and women. J Nutr 142(6):1074-80, 2012. e-Pub 2012. PMID: 22535761.
- Daniel CR, Cross AJ, Graubard BI, Park Y, Ward MH, Rothman N, Hollenbeck AR, Chow WH, Sinha R. Large prospective investigation of meat intake, related mutagens, and risk of renal cell carcinoma. Am J Clin Nutr 95(1):155-62, 2012. e-Pub 2012. PMID: 22170360.
- Daniel CR, Cross AJ, Graubard BI, Hollenbeck AR, Park Y, Sinha R. Prospective investigation of poultry and fish intake in relation to cancer risk. Cancer Prev Res (Phila) 4(11):1903-11, 2011. e-Pub 2011. PMID: 21803982.
- Daniel CR, Schwartz KL, Colt JS, Dong LM, Ruterbusch JJ, Purdue MP, Cross AJ, Rothman N, Davis FG, Wacholder S, Graubard BI, Chow WH, Sinha R. Meat-cooking mutagens and risk of renal cell carcinoma. Br J Cancer 105(7):1096-104, 2011. e-Pub 2011. PMID: 21897389.
- Mathew A, Daniel CR, Ferrucci LM, Seth T, Devesa SS, George PS, Shetty H, Devasenapathy N, Yurgalevitch S, Rastogi T, Prabhakaran D, Gupta PC, Chatterjee N, Sinha R. Assessment of follow-up, and the completeness and accuracy of cancer case ascertainment in three areas of India. Cancer Epidemiol 35(4):334-41, 2011. e-Pub 2011. PMID: 21621499.
- Nair M, Prabhakaran D, Narayan KM, Sinha R, Lakshmy R, Devasenapathy N, Daniel CR, Gupta R, George PS, Mathew A, Tandon N, Reddy KS. HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians. Prim Care Diabetes 5(2):95-102, 2011. e-Pub 2011. PMID: 21474403.
- Sinha R, Daniel CR, Devasenapathy N, Shetty H, Yurgalevitch S, Ferrucci LM, George PS, Morrissey KG, Ramakrishnan L, Graubard BI, Kapur K, Reddy KS, McAdams MJ, Rastogi T, Chatterjee N, Gupta PC, Wacholder S, Prabhakaran D, Mathew AA. Multi-center feasibility study evaluating recruitment, variability in risk factors and biomarkers for a diet and cancer cohort in India. BMC Public Health 11:405, 2011. e-Pub 2011. PMID: 21619649.
- Daniel CR, Cross AJ, Koebnick C, Sinha R. Trends in meat consumption in the USA. Public Health Nutr 14(4):575-83, 2011. e-Pub 2011. PMID: 21070685.
- Ahearn TU, McCullough ML, Flanders WD, Long Q, Sidelnikov E, Fedirko V, Daniel CR, Rutherford RE, Shaukat A, Bostick RM. A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on markers of their metabolism in normal mucosa of colorectal adenoma patients. Cancer Res 71(2):413-23, 2011. e-Pub 2011. PMID: 21084270.
- Daniel CR, Prabhakaran D, Kapur K, Graubard BI, Devasenapathy N, Ramakrishnan L, George PS, Shetty H, Ferrucci LM, Yurgalevitch S, Chatterjee N, Reddy KS, Rastogi T, Gupta PC, Mathew A, Sinha R. A cross-sectional investigation of regional patterns of diet and cardio-metabolic risk in India. Nutr J 10:12, 2011. e-Pub 2011. PMID: 21276235.
- Sidelnikov E, Bostick RM, Flanders WD, Long Q, Fedirko V, Shaukat A, Daniel CR, Rutherford RE. Effects of calcium and vitamin D on MLH1 and MSH2 expression in rectal mucosa of sporadic colorectal adenoma patients. Cancer Epidemiol Biomarkers Prev 19(4):1022-32, 2010. e-Pub 2010. PMID: 20332274.
- Fedirko V, Bostick RM, Long Q, Flanders WD, McCullough ML, Sidelnikov E, Daniel CR, Rutherford RE, Shaukat A. Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 19(1):280-91, 2010. e-Pub 2010. PMID: 20056649.
- Ferrucci LM, Daniel CR, Kapur K, Chadha P, Shetty H, Graubard BI, George PS, Osborne W, Yurgalevitch S, Devasenapathy N, Chatterjee N, Prabhakaran D, Gupta PC, Mathew A, Sinha R. Measurement of spices and seasonings in India: opportunities for cancer epidemiology and prevention. Asian Pac J Cancer Prev 11(6):1621-9, 2010. e-Pub 2010. PMID: 21338207.
- McCullough ML, Bostick RM, Daniel CR, Flanders WD, Shaukat A, Davison J, Rangaswamy U, Hollis BW. Vitamin D status and impact of vitamin D3 and/or calcium supplementation in a randomized pilot study in the Southeastern United States. J Am Coll Nutr 28(6):678-86, 2009. e-Pub 2009. PMID: 20516268.
- Fedirko V, Bostick RM, Flanders WD, Long Q, Sidelnikov E, Shaukat A, Daniel CR, Rutherford RE, Woodard JJ. Effects of vitamin d and calcium on proliferation and differentiation in normal colon mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 18(11):2933-41, 2009. e-Pub 2009. PMID: 19861511.
- Fedirko V, Bostick RM, Flanders WD, Long Q, Shaukat A, Rutherford RE, Daniel CR, Cohen V, Dash C. Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial. Cancer Prev Res (Phila) 2(3):213-23, 2009. e-Pub 2009. PMID: 19258546.
- Daniel CR, McCullough ML, Patel RC, Jacobs EJ, Flanders WD, Thun MJ, Calle EE. Dietary intake of omega-6 and omega-3 fatty acids and risk of colorectal cancer in a prospective cohort of U.S. men and women. Cancer Epidemiol Biomarkers Prev 18(2):516-25, 2009. e-Pub 2009. PMID: 19190143.
- Daniel CR, Bostick RM, Flanders WD, Long Q, Fedirko V, Sidelnikov E, Seabrook ME. TGF-alpha expression as a potential biomarker of risk within the normal-appearing colorectal mucosa of patients with and without incident sporadic adenoma. Cancer Epidemiol Biomarkers Prev 18(1):65-73, 2009. e-Pub 2009. PMID: 19124482.
Invited Articles
- Wargo JA, Ajami NJ, Daniel-MacDougall CR. Q&A with Jennifer A. Wargo, Nadim J. Ajami, and Carrie R. Daniel-MacDougall. Cell Rep Med 5(4):101509, 2024. e-Pub 2024. PMID: 38631287.
- Gok Yavuz B, Datar S, Chamseddine S, Mohamed YI, LaPelusa M, Lee SS, Hu ZI, Koay EJ, Tran Cao HS, Jalal PK, Daniel-MacDougall C, Hassan M, Duda DG, Amin HM, Kaseb AO. The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma. Cancers (Basel) 15(19), 2023. e-Pub 2023. PMID: 37835569.
- Garcia MB, Schadler KL, Chandra J, Clinton SK, Courneya KS, Cruz-Monserrate Z, Daniel CR, Dannenberg AJ, Demark-Wahnefried W, Dewhirst MW, Fabian CJ, Hursting SD, Irwin ML, Iyengar NM, McQuade JL, Schmitz KH, Basen-Engquist K. Translating energy balance research from the bench to the clinic to the community: Parallel animal-human studies in cancer. CA Cancer J Clin 73(4):425-442, 2023. e-Pub 2023. PMID: 36825928.
- Holly AE, Lee KA, Daniel CR, Spector TD, McQuade JL. Patient Nutrition: An Overlooked Yet Emerging Variable in the Precision Oncology Equation. Journal of Immunotherapy and Precision Oncology, 2020. e-Pub 2020.
- Daniel CR, McQuade JL. Nutrition and Cancer in the Microbiome Era. Trends Cancer 5(9):521-524, 2019. e-Pub 2019. PMID: 31474355.
- McQuade JL, Daniel CR, Helmink BA, Wargo JA. Modulating the microbiome to improve therapeutic response in cancer. Lancet Oncol 20(2):e77-e91, 2019. e-Pub 2019. PMID: 30712808.
- Wallace TC, Bultman S, D'Adamo C, Daniel CR, Debelius J, Ho E, Eliassen H, Lemanne D, Mukherjee P, Seyfried TN, Tian Q, Vahdat LT. Personalized Nutrition in Disrupting Cancer - Proceedings From the 2017 American College of Nutrition Annual Meeting. J Am Coll Nutr 38(1):1-14, 2019. e-Pub 2019. PMID: 30511901.
Review Articles
- Fang, A, Frigo, DE, Hahn, AW, Razouki, ZA, Hwang, J, Koutroumpakis, E, Lawen, T, Smith, MR, Hamilton-Reeves, J, DiGiovanni, J, Higgason, N, Garcia, RS, Chapin, BF, Pettaway, CA, Chery, LJ, Troncoso, P, Logothetis, CJ, Daniel-MacDougall, CR, Wei, P, Gregg, JR. GLP-1 Agonist Use Among Men With Localized Prostate Cancer. Urology 201:152-158, 2025. e-Pub 2025. PMID: 40348027.
- Raber M, Liao Y, Rara A, Schembre SM, Krause KJ, Strong L, Daniel C, Basen-Engquist K. A systematic review of the use of dietary self-monitoring in behavioural weight loss interventions: delivery, intensity and effectiveness. Public Health Nutr 24(17):1-29, 2021. e-Pub 2021. PMID: 34412727.
Other Articles
- Koslovsky MD, Hoffman KL, Daniel-MacDougall CR, Vannucci M CORRECTION. Annals of Applied Statistics 16(1):625, 2022.
Editorials
- Fedirko V, Kopetz S, Daniel CR. Diverticular disease and cancer risk: More than a gut feeling. J Natl Cancer Inst 115(1):12-13, 2023. PMID: 36200895.
Abstracts
- Cass S, Wargo J, Pettaway C, Pisters L, Davis J, Chapin B, Ward J, Daniel CR, Gregg J. A novel Mediterranean dietary intervention for prostate cancer. Cancer Res 82 (12_Supplement): 3495, 2022.
- Spencer C, Gopalakrishnan V, McQuade J, Andrews MC, Helmink B, Khan MA, Sirmans E, Haydu L, Cogdill A, Burton E, Amaria R, Patel S, Glitza I, Davies M, Posada E, Hwu W, Diab A, Nelson K, Tawbi H, Wong M, Jenq RR, Cohen L, Daniel CR, Wargo JA. Abstract 2838: The gut microbiome (GM) and immunotherapy response are influenced by host lifestyle factors 79 (13_Supplement): 2838, 2019.
- Gopalakrishnan V, Spencer CN, McQuade JL, Andrews M, Helmink B, Cogdill AP, Khan AW, Sirmans E, Haydu LE, Posada E, Burton E, Glitza IC, Amaria RN, Patel S, Diab A, Wong MK, Tawbi HA, Hwu WJ, Davies M, Hwu P, Jenq R, Nelson K, Daniel CR, Cohen L, Wargo JA. The gut microbiome of metastatic melanoma patients initiating systemic therapy is influenced by host factors including diet, probiotic and antibiotic use. Journal for ImmunoTherapy of Cancer 6(Suppl 1):115 (P505), 2018. e-Pub 2018.
- Liao Y, Desai N, Song J, Li L, Shen Q, Daniel CR, Kopetz S, Basen-Engquist K, Schembre SM. Explore effects of free-living physical activity on next 24-hr glucose patterns using mobile glucose monitors in non-diabetics. Annals of Behavioral Medicine 52:S595-S595, 2018. e-Pub 2018.
- McQuade JL, Warner AB, Li M, Chon J, Haydu LE, Daniel CR, Hess KR, Johnson DB, Menzies AM, Davies MA, Shoushtari AN. Association of body mass index (BMI) with overall survival (OS) in metastatic melanoma (MM) patients (pts) treated with combined anti-CTLA4 + anti-PD1. Journal of Clinical Oncology 36:15_suppl, 9562-9562, 2018. e-Pub 2018.
- Gopalakrishnan V, Spencer CN, Reuben A, Prieto P, Vicente D, Karpinets TV, Hudgens CW, Hutchinson DS, Tetzlaff M, Lazar A, Davies MA, Gershenwald JE, Jenq R, Hwu P, Sharma P, Allison J, Futreal A, Ajami N, Petrosino J, Daniel CR, Wargo JA. Response to anti-PD-1 based therapy in metastatic melanoma patients is associated with the diversity and composition of the gut microbiome 10.1158/1538-7445.AM2017-2672, 2017. e-Pub 2017.
- Strong LL, Basen-Engquist K, Daniel CR, McNeill L, Hoover DS, Dominguez E, Christie I. Promoting physical activity in Dyads of African American and Hispanic women through social networking and mobile technology. ANNALS OF BEHAVIORAL MEDICINE 51:S756-S757, 2017. e-Pub 2017.
- Gopalakrishnan V, Spencer C, Reuben A, Karpinets T, Hutchinson D, Hoffman K, Prieto PA, Tetzlaff MT, Lazar A, Davies MA, Gershenwald JE, Jenq RR, Hwu P, Sharma P, Allison JP, Futreal A, Ajami N, Petrosino J, Daniel CR, Wargo JA. Association of diversity and composition of the gut microbiome with differential responses to PD-1 based therapy in patients with metastatic melanoma. Journal of Clinical Oncology 35:7_suppl, 2-2, 2017. e-Pub 2017.
- Daniel CR, Hoffman KL, Raju GS, Hanash SM, Hutchinson DS, Ajami NJ, Fowler RG, Browman GJ, Sood A, Scheet PA, Wu X, Petrosino JF. Evidence of early colorectal cancer risk and prevention pathways in the fecal microbiome of colonoscopy patients: Associations with diet and circulating adipocytokines. AACR Annual Meeting, 2017. e-Pub 2017.
- Schembre S, Hoffman K, Versace F, Petrosini J, Daniel CR. Gut microbiome profiles vary by the propensity to attribute incentive salience to palatable food cues in humans. Psychoneuroendocrinology 71:69, 2016. e-Pub 2016.
- Hoffman KL, Chow WH, Smith DP, Zhang J, Hutchinson DS, Ajami NJ, Petrosino JF, Daniel CR. Oral microbiome predicts 5-yr significant weight gain in Mexican-American women. 2016 Keystone Symposium on Gut Microbiota, Metabolic Disorders and Beyond, 2016. e-Pub 2016.
- Daniel CR, Hoffman KL, Sood A, Raju GS, Hanash SM, Wu X, Petrosino JF. Diet quantity versus quality in relation to the fecal microbiome among colonoscopy patients. AACR Colorectal Cancer: From Initiation to Outcomes, 2016. e-Pub 2016.
- Schembre SS, Hoffman KL, Versace F, Petrosino JF, Daniel CR. Hedonic eating and the microbiome in humans. 29th European College of Neuropsychopharmacology Congress, 2016. e-Pub 2016.
- Sood A, Hoffman KL, Raju GS, Wu X, Hanash SM, Petrosino JF, Daniel CR. Early risk signatures in the fecal microbiota of colonoscopy patients. International Human Microbiome Consortium 6th Congress, 2016. e-Pub 2016.
- Palacios C, Daniel CR, Tirado-Gómez M, Gonzalez-Mercado V, Liliana J, Lozada J, Hughes DC, Strom S, Basen-Engquist K. Abstract B14: Dietary patterns in Puerto Rican and Mexican-American breast cancer survivors: A pilot study. Cancer Epidemiology and Prevention Biomarkers 24(10 Supplement):B14-B14, 2015. e-Pub 2015.
- Tu H, Daniel CR, Melkonian SM, Ye Y, Raju GS, Wu X. Body mass index, weight gain, and physical activity during adulthood in relation to colorectal cancer risk. AACR Annual Meeting, 2015. e-Pub 2015.
- Schembre SS, Versace F, Petrosino JF, Daniel CR. Gut microbiome-brain interactions in hedonic eating behaviors. American Psychosomatic Society Conference, 2015. e-Pub 2015.
- Melkonian SC, Daniel CR, Ye Y, Tannir NM, Karam JA, Matin SF, Wood CG, Wu X. Gene-Environment Interaction of Genome-Wide Association Study-Identified Susceptibility Loci and Meat-Cooking Mutagens in Renal Cell Carcinoma Etiology. AACR Annual Meeting, 2015. e-Pub 2015.
- Advani S, Overman M, Fogelman D, Kee, Lee, Manuel S, Davis JS, Daniel CR, Menter D, Hamilton S, Maru D, Kopetz S. Correlation of CpG Island Methylation with Clinical and Pathology Characteristics in Metastatic Colorectal Cancer Patients. AACR Annual Meeting, 2015. e-Pub 2015.
- Daniel CR, Shu X, Ye Y, Gu J, Raju GS, Kopetz S, Wu X. Severe obesity and colorectal cancer patient survival. AACR, 2015. e-Pub 2015.
- Davis JS, Advani S, Banfield E, Overman M, Jiang ZQ, Manuel S, Daniel CR, Chang S, Kopetz S. Demographics of colorectal cancer patients vary by NSAID use. AACR Annual Meeting, 2015. e-Pub 2015.
- Strong LL, Forman MR, Christie I, Daniel CR, Zhao H, Bondy M, Wilkinson AV. Associations of different forms of physical activity with weight status in Mexican-origin adolescents. Society of Behavioral Medicine, 2015. e-Pub 2015.
- Fogelman DF, Daniel CR, Zhang J, Kopetz S. The relationship of visceral adipose to inflammation in metastatic colorectal cancer patients. Support Care Cancer 23(Suppl 1):S1–S388, 2015. e-Pub 2015.
- Han L, Zhao H, Strom S, Daniel CR, Chang D, Zhang H, Ye Y, Gu J, Chow WH, Wu X. Telomere length linking social contexts and cancer risk in Mexican Americans. AACR 5038, 2014. e-Pub 2014.
- Palacios C, Daniel CR, Tirado-Gomez M, Gonzalez-Mercado V, Vallejo L, Lozada J, Hughes DC, Basen-Engquist K. Dietary patterns in two groups of Hispanic breast cancer survivors. AACR Cancer Health Disparities, 2014. e-Pub 2014.
- Melkonian S, Daniel CR, Hildebrandt M, Tannir N, Ye Y, Chow WH, Wood C, Wu X. Established genetic variants and dietary patterns jointly impact risk of renal cell carcinoma in non-Hispanic whites. AACR 1262, 2014. e-Pub 2014.
- Shah MS, Fogelman DR, Daniel CR, Raghav KPS, Heymach J, Tran H, Jiang Z, Kopetz S. II-8 may be an underutilized prognostic factor in metastatic colorectal cancer, 2013. e-Pub 2013.
- Fogelman D, Shah M, Kopetz S, Daniel CR. Prediction of weight loss in metastatic colorectal cancer, 2013. e-Pub 2013.
- Tu H, Woodard J, Daniel CR, Gonzalez-Feliciano A, Ahearn T, Bostick RM. Markers of cell proliferation and growth as potential preneoplastic biomarkers of risk for colorectal neoplasms 73(8 Supplement):121-121, 2013. e-Pub 2013.
- Daniel CR, Chow WH, Park Y, Graubard BI, Hollenbeck AR, Sinha R. Intake of fiber and fiber-rich plant foods associated with lower risk of renal cell carcinoma in a large U.S. cohort. Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research, 2012. e-Pub 2012.
- Tu H, Daniel CR, Gonzalez-Feliciano AG, Ahearn TU, Bostick RM. Effects of calcium and vitamin D on TGFα and TGFβ1 expression in rectal mucosa of sporadic colorectal adenoma patients: a randomized controlled trial. Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research, 2012. e-Pub 2012.
- Daniel CR, Cross AJ, Park Y, Hollenbeck AR, Schatzkin A, Sinha R. Intake of poultry and fish and risk of cancer in the NIH-AARP Diet and Health Study. FASEB, 2011. e-Pub 2011.
- Daniel CR, Graubard B, Kapur K, Chadha P, Shetty H, Dixit-Joshi S, Yurgalevitch S, Morrissey KG, Mathew A, Sinha R. Dietary patterns and markers of health and nutritional status in a diverse Asian-Indian population: Preliminary results of the India Health Study. Indigenous Populations and Traditional Food Systems. International Conference on Diet and Activity Methods (ICDAM) 7, 2009. e-Pub 2009.
- Fedirko V, Daniel C, Dash C, Bostick RM. Markers of differentiation, apoptosis, dietary oxidative stress, inflammation and B-vitamins in the Markers of Adenomatous Polyps II Case-Control Study. AACR, 2007. e-Pub 2007.
- Daniel CR, Gonzalez-Feliciano A, Fedirko V, Dash C, Shaukat A, Bostick RM. Western diet and lifestyle risk factors and colon crypt expression of TGFalpha;, TGFbeta1, and TGFbetaRII in the Markers of Adenomatous Polyps II case-control study. FASEB, 2007. e-Pub 2007.
- Shaukat S, Dash C, Daniel CR, Cohen V, Bostick RM. Expression of APC in normal-appearing rectal mucosa differs between those with and without incident, sporadic colorectal adenomatous polyps and may be modulated 15(12 Supplement):A13-A13, 2006. e-Pub 2006.
- Fedirko V, Daniel CR, Bostick RM. Bcl-2, bax, and bak levels in colon crypts and colon cancer risk factors in the Markers of Adenomatous Polyps II case-control study. Proc AACR, 2006. e-Pub 2006.
- Toussaint E, Daniel CR, Fedirko V, Bostick RM. Associations of COX-2 levels in colon crypts with colon cancer risk factors and serum levels of C-reactive protein. Proc AACR, 2006. e-Pub 2006.
- Gonzalez-Feliciano A, Bostick RM, Fedirko V, Dash C, Shaukat-Bhatti A, Daniel CR. TGFbeta1 expression in normal-appearing rectal mucosa in individuals with and without sporadic colorectal adenomatous polyps. Proc 5th Annual AACR Intl Conf Frontiers Cancer Prev Res, 2006. e-Pub 2006.
- Shaukat A, Daniel CR, Coker WJ, Toma-Drane M, Kennedy V, Flanders WD, Bostick RM. Expression of APC in normal-appearing rectal mucosa differs between those with and without incident, sporadic colorectal adenomatous polyps: results from the Markers of Adenomatous Polyps II (MAP II) case-control study. ProcAACR, 2005. e-Pub 2005.
- Daniel CR, Bostick RM, Shaukat A, Coker WJ, Mizzel J, Toma-Drane M, Kennedy V, Flanders WD. TGFalpha; and TGFbeta1 levels in colon crypts, colon cancer risk factors, and incident, sporadic colorectal adenomas in the Markers of Adenomatous Polyps II (MAPII) case-control study. ProcAACR, 2005. e-Pub 2005.
- Farias R, Jiang Y, Jenkins CA, Levy EJ, Montalvo M, Duncan S, Sirmans E, Rains J, Wang J, Kuss TM, Burton EM, Ajami NJ, Wargo JA, Daniel CR, McQuade JL. The DIET study: A randomized controlled trial of a high fiber diet in cancer patients (pts) receiving immune checkpoint blockade (ICB). Journal of Clinical Oncology 41(16_suppl).
- Sims TT, Colbert LE, Zheng J, Ramondetta L, Jazaeri A, Frumovitz M, Jhingran A, Schmeler K, Daniel-MacDougall CR, Klopp A. Gut microbial diversity and genus-level differences identified in cervical cancer patients versus age and BMI matched healthy controls. SGO 50th Annual Meeting on Women's Cancer 2019. PMID: 31500892.
Book Chapters
- Fedirko V, Nead KT, Daniel CR, Scheet P. Cancer Epidemiology. In: In Holland-Frei Cancer Medicine (eds R.C. Bast, W.N. Hait, D.W. Kufe, R.R. Weichselbaum, J.F. Holland, C.M. Croce, M. Piccart-Gebart, H. Wang, W.K. Hong and R.E. Pollock). John Wiley & Sons, 2022.
- Zhang X, Daniel CR. Diet, Microbiome, Inflammation, and Cancer. In: Inflammation, Infection, and Microbiome in Cancers: Evidence, Mechanisms, and Implications. Springer, 329-348, 2021.
- Daniel TC, Valdiserri M, Daniel CR, Jakes P, Barro S. Social science to improve fuels management: A synthesis of research on assessing social acceptability of fuels treatments. In: General Technical Report. U.S. Department of Agriculture, Forest Service, North Central Research Station, 52 p, 2005.
Letters to the Editor
- McQuade JL, Daniel CR, Hess KR, Davies MA. Sex as a predictor of response to cancer immunotherapy. Lancet Oncol 19: e376, 2018.
- McQuade JL, Daniel CR, Davies MA. Body-mass index and metastatic melanoma outcomes - Authors' reply. Lancet Oncol 19: e227-e228, 2018.
Patient Reviews
CV information above last modified August 27, 2025